Loading…

Clinical characteristics and prognostic factors of malignant tumors involving pterygopalatine fossa

Background To identify the clinical characteristics and prognostic factors of malignancies involving the pterygopalatine fossa (PPF). Methods Fifty‐seven patients who underwent curative surgery for malignant tumor involving PPF were reviewed. Results The rates for three‐year local control (LC), five...

Full description

Saved in:
Bibliographic Details
Published in:Head & neck 2020-02, Vol.42 (2), p.281-288
Main Authors: Woo, Hyun‐Jae, Hwang, Peter H., Kaplan, Michael J., Choby, Garret
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background To identify the clinical characteristics and prognostic factors of malignancies involving the pterygopalatine fossa (PPF). Methods Fifty‐seven patients who underwent curative surgery for malignant tumor involving PPF were reviewed. Results The rates for three‐year local control (LC), five‐year disease‐free survival (DFS) and five‐year overall survival (OS) were 55.4%, 34.5%, and 52.7%, respectively. Perineural invasion (PNI) of the maxillary nerve with facial numbness (symptomatic V2 PNI) (P = .04) and cranial involvement (P = .03) were predictors for poor OS. Symptomatic V2 PNI was also a significant predictor for poor LC (P = .05) and DFS (P = .03). Within the subgroup analysis of patients with pathologically confirmed V2 PNI, asymptomatic V2 PNI patients had significantly better LC (71.2% vs 31.8%, P = .05) and DFS (43.8% vs 17.3%, P = .05) compared to symptomatic patients. Conclusion Malignant tumors involving the PPF have diverse pathologies and a poor prognosis. Symptomatic V2 PNI may be an independent poor prognostic factor.
ISSN:1043-3074
1097-0347
DOI:10.1002/hed.26000